MEF2A is a transcriptional activator that binds the MEF2 DNA element to regulate muscle-specific and growth factor-induced genes. Beyond its classical role in cardiac and skeletal muscle development, MEF2A functions in neuronal differentiation, endothelial cell homeostasis, and metabolic regulation through diverse signaling mechanisms. Mechanistically, MEF2A operates as a context-dependent regulator. In endothelial cells, MEF2A-eNOS signaling is suppressed by HDAC4 translocation; AQP1-mediated H2O2 transport exacerbates this suppression in proliferating cells while promoting senescence in aged cells 1. In fibroblasts, HDAC5 represses MEF2A binding to the Smad7 promoter, thereby controlling TGF-β signaling and fibrotic responses 2. MEF2A also activates CYP7A1 transcription to regulate hepatic cholesterol metabolism, an effect suppressible by promoter DNA hypermethylation following maternal high-fat diet exposure 3. In gastric cancer, MEF2A drives chemoresistance by activating PGC1α-mediated mitochondrial biogenesis and suppressing KEAP1, thereby modulating oxidative stress 4. Clinically, MEF2A mutations associate with coronary artery disease; specifically, rare 21-bp deletions show stronger CAD association than common CAG repeats, though the latter lacks consistent evidence 5. MEF2A polymorphisms show limited correlation with warfarin sensitivity in cardiovascular patients 6. Additionally, MEF2A functions in melanoma progression through enhancer-mediated regulation 7, and exhibits dual activator-repressor roles in macrophage differentiation 8.